These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 11676116)

  • 1. Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis).
    Saple DG; Amar AK; Ravichandran G; Korde KM; Desai A
    J Indian Med Assoc; 2001 May; 99(5):274-5. PubMed ID: 11676116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butenafine: an update of its use in superficial mycoses.
    Gupta AK
    Skin Therapy Lett; 2002 Sep; 7(7):1-2, 5. PubMed ID: 12432425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial.
    Singal A; Pandhi D; Agrawal S; Das S
    J Dermatolog Treat; 2005; 16(5-6):331-5. PubMed ID: 16428155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial.
    Lesher JL; Babel DE; Stewart DM; Jones TM; Kaminester L; Goldman M; Weintraub JS
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S20-4. PubMed ID: 9039201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
    Lebwohl M; Elewski B; Eisen D; Savin RC
    Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butenafine and superficial mycoses: current status.
    Singal A
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):999-1005. PubMed ID: 18624686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butenafine hydrochloride: for the treatment of interdigital tinea pedis.
    Syed TA; Maibach HI
    Expert Opin Pharmacother; 2000 Mar; 1(3):467-73. PubMed ID: 11249531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
    Jegasothy BV; Pakes GE
    Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical butenafine for tinea pedis.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):63-4. PubMed ID: 9217695
    [No Abstract]   [Full Text] [Related]  

  • 13. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
    Savin R; De Villez RL; Elewski B; Hong S; Jones T; Lowe N; Lucky A; Reyes B; Stewart D; Willis I
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent.
    Greer DL; Weiss J; Rodriguez DA; Hebert AA; Swinehart JM
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):231-5. PubMed ID: 9270509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris.
    Faergemann J; Mörk NJ; Haglund A; Odegård T
    Br J Dermatol; 1997 Apr; 136(4):575-7. PubMed ID: 9155961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs.
    Arika T; Yokoo M; Maeda T; Amemiya K; Yamaguchi H
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2254-5. PubMed ID: 2073117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised controlled trial of topical butenafine in tinea cruris and tinea corporis.
    Ramam M; Prasad HR; Manchanda Y; Khaitan BK; Banerjee U; Mukhopadhyaya A; Shetty R; Gogtay JA
    Indian J Dermatol Venereol Leprol; 2003; 69(2):154-8. PubMed ID: 17642865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment of common superficial tinea infections.
    Weinstein A; Berman B
    Am Fam Physician; 2002 May; 65(10):2095-102. PubMed ID: 12046779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ajoene in the topical short-term treatment of tinea cruris and tinea corporis in humans. Randomized comparative study with terbinafine.
    Ledezma E; López JC; Marin P; Romero H; Ferrara G; De Sousa L; Jorquera A; Apitz Castro R
    Arzneimittelforschung; 1999 Jun; 49(6):544-7. PubMed ID: 10417874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common tinea infections in children.
    Andrews MD; Burns M
    Am Fam Physician; 2008 May; 77(10):1415-20. PubMed ID: 18533375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.